22.04

3.09% -0.69

Elanco Animal Health Inc (ELAN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$22.73

Aprire:

$22.4

Volume 24 ore:

4.57M

Relative Volume:

0.70

Capitalizzazione di mercato:

$11.01B

Reddito:

$4.89B

Utile/perdita netta:

$-242.00M

Rapporto P/E:

-45.07

EPS:

-0.489

Flusso di cassa netto:

$315.00M

1 W Prestazione:

-15.99%

1M Prestazione:

-11.25%

6M Prestazione:

-11.14%

1 anno Prestazione:

+26.38%

Intervallo 1D:

$21.75

$22.50

Intervallo di 1 settimana:

$21.32

$25.34

Portata 52W:

$17.11

$27.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Nome

Elanco Animal Health Inc

Settore

Healthcare (1086)

Industria

Drug Manufacturers - Specialty & Generic (88)

Telefono

877-352-6261

Indirizzo

450 ELANCO CIRCLE, INDIANAPOLIS

Dipendente

9,900

Cinguettio

@Elanco

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

ELAN's Discussions on Twitter

Compare ELAN vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ELAN Elanco Animal Health Inc	22.03	11.36B	4.89B	-242.00M	315.00M	-0.489
TAK Takeda Pharmaceutical Co Adr	17.39	55.82B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.815	43.73B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	36.62	42.51B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	73.50	31.14B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	512.78	22.11B	3.17B	1.29B	1.01B	27.09

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-15	Iniziato	Citigroup	Buy
2026-01-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-12-09	Iniziato	Barclays	Overweight
2025-11-21	Iniziato	KeyBanc Capital Markets	Overweight
2025-11-19	Aggiornamento	Argus	Hold → Buy
2025-10-07	Aggiornamento	JP Morgan	Neutral → Overweight
2025-07-17	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-06-26	Aggiornamento	William Blair	Mkt Perform → Outperform
2024-12-09	Iniziato	UBS	Buy
2024-12-02	Iniziato	Leerink Partners	Market Perform
2024-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Aggiornamento	Stifel	Hold → Buy
2023-12-19	Iniziato	Jefferies	Buy
2023-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-04-20	Aggiornamento	Barclays	Equal Weight → Overweight
2022-08-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Downgrade	JP Morgan	Overweight → Neutral
2022-07-21	Downgrade	Goldman	Buy → Sell
2022-07-12	Iniziato	Piper Sandler	Neutral
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-10-28	Downgrade	Stifel	Buy → Hold
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-06-15	Aggiornamento	Cleveland Research	Underperform → Neutral
2021-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2021-05-11	Aggiornamento	Gabelli & Co	Hold → Buy
2021-04-15	Iniziato	Stifel	Buy
2021-03-22	Downgrade	Gabelli & Co	Buy → Hold
2021-02-26	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-09	Downgrade	Argus	Buy → Hold
2020-11-09	Downgrade	Barclays	Overweight → Underweight
2020-08-20	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Ripresa	Credit Suisse	Neutral
2020-08-04	Ripresa	Goldman	Buy
2020-07-27	Downgrade	Cleveland Research	Neutral → Underperform
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Iniziato	Raymond James	Mkt Perform
2019-12-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-11-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Iniziato	Barclays	Overweight
2019-08-26	Downgrade	BofA/Merrill	Buy → Neutral
2019-08-15	Aggiornamento	UBS	Sell → Neutral
2019-05-23	Iniziato	Guggenheim	Neutral
2019-03-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-03-13	Ripresa	Morgan Stanley	Equal-Weight
2019-02-12	Iniziato	William Blair	Mkt Perform
2019-01-23	Iniziato	UBS	Sell
2019-01-15	Iniziato	Argus	Buy
2018-10-15	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

05:02 AM

Elanco (ELAN): Innovation Is Turning A Leveraged Portfolio Into A Share-Taking Platform - Seeking Alpha

05:02 AM

Aug 11, 2026

Elanco Animal Health (ELAN) Insider Buying: EVP and CFO Robert V - GuruFocus

Aug 11, 2026

Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Speci - ACCESS Newswire

Aug 11, 2026

Aug 10, 2026

Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Buys $96,936.00 in Stock - MarketBeat

Aug 10, 2026

Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock - MarketBeat

Aug 10, 2026

ELAN Stock Jumps As Earnings Beat Fuels Bullish Guidance - StocksToTrade

Aug 10, 2026

Elanco Animal Health (NYSE: ELAN) EVP granted new deferred stock units - Stock Titan

Aug 10, 2026

Elanco (ELAN) CEO Jeffrey Simmons receives new deferred stock unit grant - Stock Titan

Aug 10, 2026

Elanco Animal Health (NYSE: ELAN) director buys 10,000 shares at $23.69 - Stock Titan

Aug 10, 2026

Bank of America Corp DE Has $80.36 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat

Aug 10, 2026

Aug 09, 2026

Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win? - Yahoo! Finance Canada

Aug 09, 2026

Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus - Yahoo Finance

Aug 09, 2026

Aug 08, 2026

INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigati - The National Law Review

Aug 08, 2026

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Aug 08, 2026